Phase I Trial of Combined Immune Cell Therapy for Metastatic Stage IV Solid Tumors (SDH-Combi)
NCT06296056 · Status: COMPLETED · Phase: PHASE1 · Type: INTERVENTIONAL · Enrollment: 9
Last updated 2025-10-01
Summary
To evaluate the safety and potential efficacy of combined immune cell therapy in patients with stage IV solid tumors who have failed standard treatment and have unresectable lesions or metastatic lesions.
Conditions
- Solid Tumors
- Metastatic
Interventions
- BIOLOGICAL
-
Combi
Biological immune cell therapy
Sponsors & Collaborators
-
Seoul Hospital
lead OTHER
Study Design
- Allocation
- NA
- Purpose
- TREATMENT
- Masking
- NONE
- Model
- SINGLE_GROUP
Eligibility
- Min Age
- 19 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2024-08-01
- Primary Completion
- 2025-05-28
- Completion
- 2025-06-08
Countries
- Mongolia
Study Locations
More Related Trials
-
Immunotherapy Rechallenge in Patients with Solid Tumors in Clinical Trials
NCT06612632 ·Status: RECRUITING ·Phase: PHASE1/PHASE2
-
A Study of FDA022-BB05 in Subjects With Advanced Solid Malignant Tumors
NCT05564858 ·Status: RECRUITING ·Phase: PHASE1
-
The Therapeutic Effect of Immunotherapy in Patients With Advanced Lung Squamous Carcinoma
NCT06647836 ·Status: ENROLLING_BY_INVITATION
-
γδ T-PD-1 Ab Cells in the Treatment of Advanced Solid Tumors
NCT06404281 ·Status: RECRUITING ·Phase: PHASE1
-
Induction Therapy With PD-1 Antibody Combined With Platinum-based Doublet Chemotherapy for Locally-advanced Non-small Cell Lung Cancer
NCT05766800 ·Status: RECRUITING ·Phase: PHASE2
-
Safety and Efficacy of an Anticancer Medication Combined With Immune Cells in Subjects With Solid Tumors
NCT03472352 ·Status: UNKNOWN ·Phase: PHASE1
-
Study of Recombinant Human Anti-PD-1 Monoclonal Antibody in Patients With Advanced Tumours
NCT03852823 ·Status: UNKNOWN ·Phase: PHASE1
-
Combination Immunotherapy Targeting Sarcomas
NCT04433221 ·Status: UNKNOWN ·Phase: PHASE1/PHASE2
-
A Study of CM350 in Patients With Advanced Solid Tumors
NCT05263960 ·Status: RECRUITING ·Phase: PHASE1/PHASE2
-
Study of αPD1-MSLN-CAR T Cells to Evaluate the Safety, Tolerability, and Effectiveness for Patients With MSLN-positive Advanced Solid Tumors
NCT05089266 ·Status: UNKNOWN ·Phase: PHASE1
-
A Clinical Study of SPH6516 Tablets in the Treatment of Advanced Solid Tumors.
NCT06266923 ·Status: COMPLETED ·Phase: EARLY_PHASE1
-
The Clinical Characteristics and Efficacy of Immunotherapy in First-line PD-L1-negative Advanced NSCLC Patients
NCT06496009 ·Status: NOT_YET_RECRUITING
-
Phase I/II Study of SCTB39G in Advanced Solid Tumours
NCT07077252 ·Status: NOT_YET_RECRUITING ·Phase: PHASE1/PHASE2
-
A Study to Evaluate the Efficacy and Safety of Anti-PD-1 Antibody AK105 in Patients With Selected Advanced Solid Tumors
NCT04172506 ·Status: COMPLETED ·Phase: PHASE1/PHASE2
-
Study of Split-course Chemoradiotherapy For Locally Advanced None-small Cell Lung Cancer
NCT02573506 ·Status: COMPLETED ·Phase: PHASE2
-
Safety and Efficacy Evaluation of 4th Generation Safety-engineered CAR T Cells Targeting Sarcomas
NCT03356782 ·Status: UNKNOWN ·Phase: PHASE1/PHASE2
-
A Clinical Research About CD70-targeted CAR-T in the Treatment of CD70-positive Advanced/Metastatic Solid Tumors
NCT06010875 ·Status: RECRUITING ·Phase: PHASE1
-
A Phase Ia/Ib Study of GH2616 Tablet in Subjects With Advanced Solid Tumors
NCT06329206 ·Status: RECRUITING ·Phase: PHASE1
-
ADG126 in Combination With Pembrolizumab in Patients With Advanced/Metastatic Solid Tumors
NCT05405595 ·Status: RECRUITING ·Phase: PHASE1/PHASE2
-
Safety, Tolerability, Pharmacokinetics and Preliminary Efficacy of SCT200 in Patients With Advanced Solid Tumors
NCT03692520 ·Status: UNKNOWN ·Phase: PHASE1
-
First-line Treatment for ES-SCLC with Chemotherapy Combined with PD-1/PD-L1 Inhibitor Sequential Thoracic Radiotherapy
NCT06586697 ·Status: RECRUITING ·Phase: PHASE2
-
A Phase I Study of SIM0609 in Adult Participants With Locally Advanced/Metastatic Solid Tumors
NCT07265921 ·Status: RECRUITING ·Phase: PHASE1
-
SMET12 and Toripalimab Combined Chemotherapy in Patients With EGFR Positive Advanced Non-small Cell Lung Cancer (NSCLC)
NCT06208033 ·Status: NOT_YET_RECRUITING ·Phase: EARLY_PHASE1
-
A Study of SBRT in Combination With rhGM-CSF for Stage IV NSCLC Patients Who Failed in Second-line Chemotherapy
NCT02623595 ·Status: WITHDRAWN ·Phase: PHASE2
-
A Clinical Study to Evaluate Safety, Tolerance, Pharmacokinetics and Efficacy of Sc610 Injection for Treating Advanced Urinary System Tumors
NCT05633589 ·Status: UNKNOWN ·Phase: PHASE1/PHASE2